Risperdal (risperidone) is an anti-psychotic drug that has been found to cause unusual male breast growth adolescent boys and young men. Risperdal is used to treat schizophrenia, Bipolar I Disorder, and autism in children and adults by altering the body's hormonal balance. The drug increases the body's store of prolactin, the hormone responsible for breast growth and lactation in females. Male breast growth, or gynecomastia, is rarely a medical problem but it can result in shame, derision, and undue suffering for young men. Boys and the family members of boys who have suffered from male breast growth while taking Risperdal may be entitled to real compensation through a Risperdal breast lawsuit.
Johnson & Johnson, the pharmaceutical giant responsible for Risperdal, has been accused of downplaying the effects of excess prolactin. Many boys taking the drug were unaware that growing breasts was a potential side effects of the treatment. Boys who suffer from Risperdal gynecomastia may require mastectomy surgery and years of therapy or psychiatric treatment as a result of the significant mental anguish and trauma that may accompany male breast growth.
The tendency for Risperdal to cause breasts in boys is not the only controversy about the drug. Risperdal has been the subject of litigation on the state and federal levels, most prominently a record $2.2 billion settlement with the Justice Department in 2013 due to allegations of fraudulent advertising, illegal kickbacks for off-label uses, and a failure to properly disclose Risperdal health risks.
Young men and boys who have experienced male breast growth as a result of taking Risperdal may be eligible to receive real compensation through filing a Risperdal breast lawsuit against Johnson & Johnson to make up for the cost of mastectomy and other medical expenses, psychiatric care, mental anguish, and other harm. The suffering encountered by young males who grew breasts while taking Risperdal cannot be overstated, as the negative consequences may affect the future course of their lives.
Our attorneys provide free Risperdal claim reviews, and are available to answer your questions and inform you of your legal options. All Risperdal gynecomastia lawsuit services are provided on a contingency basis, meaning there are no legal fees unless we win compensation on your behalf.
Filing a lawsuit is the best means for individual consumers to hold pharmaceutical companies accountable for harmful products. By placing profit motives ahead of consumer safety, Johnson & Johnson has caused undue harm and loss to Americans and their families while reaping the benefits of product sales. Risperdal is one among several flawed and dangerous products produced by Johnson & Johnson is recent years, also including Tylenol products for the risk of severe liver damage and defective DePuy hip replacement parts. Negligent and unscrupulous pharmaceutical companies canâ€”and shouldâ€”be held accountable for their actions, and injured consumers have a right to seek justice. Filing a Risperdal lawsuit enables consumers to hold the companies accountable for the safety of their products.
The Onder Law Firm has a national reputation for its work in family and consumer safety based on an ethic of hard work, reliable advice, and achieving results on behalf of our clients. We will work tirelessly to ensure each of our clients has trustworthy and excellent legal representation. Contact our attorneys to ensure you have an experienced advocate fighting on behalf of your family.
To speak with a lawyer handling Risperdal boys' breast claims, contact our firm today. For more information, please visit our Risperdal Gynecomastia Lawsuit Center.
Scott G Williams MD, FACOG
Dr Williams is a board certified obstetrician/gynecologist who serves as chief medical consultant for Onder Law. During more than 20 years as a practicing ob/gyn in St Charles county, Dr Williams delivered thousands of babies, performed surgery on a daily basis, and was considered one of the top providers in his profession. He served as chief of ob/gyn at two of the three hospitals in St Charles county, and currently is the full time medical director of St Louis area obstetric hospitalist program.
In addition, Dr Williams has served as a long time consultant in medical and pharmaceutical litigation for Onder Law. With a background that includes scientific research as well as medical practice, Dr Williams is adept at interpreting pharmaceutical and medical device studies. His past analyses have included research on the harmful effects of contraceptive devices, talc/ ovarian cancer and the blood clotting effects of certain oral contraceptives.
Clients would not commonly meet with Dr Williams as he is not an attorney, but his expertise forms an important part of Onder Law's client strategies for medical and pharmaceutical products. Dr Williams is often a crucial "behind the scenes" part of formulating a winning approach for your case.
Scott G Williams, MD, FACOG, is a 1986 graduate of the University of Notre Dame. His MD was earned at the University of Missouri Columbia and he completed residency at the well regarded University of Florida-Gainesville Ob/Gyn program. Dr Williams and his wife (who is also a physician) live with two labrador retrievers; their son and daughter are at college.